Illumina shareholders have voted to oust the company’s chairman John Thompson, although chief executive Francis DeSouza has emerged from the annual meeting unscathed.
The Federal Trade Commission has ordered Illumina to divest Grail, the cancer detection business it bought for $7.1 billion in 2021, saying it will “stifle” competition an
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
